ACADIA Pharmaceuticals
14713 W 49th Ct
Shawnee, Kansas 66216-5135
913-206-2298
info@acadia.com
Acadia is trailblazing breakthroughs in
neuroscience to elevate life. For more than 25 years we have been
working at the forefront of healthcare to bring vital solutions to
people who need them most. We developed and commercialized the first and
only approved therapy for hallucinations and delusions associated with
Parkinson’s disease psychosis. Our late-stage development efforts are
focused on dementia-related psychosis, negative symptoms of schizophrenia
and Rhett syndrome, and in early-stage clinical research we are
exploring novel approaches to pain management, and cognition and
neuropsychiatric symptoms in central nervous system disorders. For more
information, visit us at www.Acadia.com and follow us on LinkedIn
and Twitter.
neuroscience to elevate life. For more than 25 years we have been
working at the forefront of healthcare to bring vital solutions to
people who need them most. We developed and commercialized the first and
only approved therapy for hallucinations and delusions associated with
Parkinson’s disease psychosis. Our late-stage development efforts are
focused on dementia-related psychosis, negative symptoms of schizophrenia
and Rhett syndrome, and in early-stage clinical research we are
exploring novel approaches to pain management, and cognition and
neuropsychiatric symptoms in central nervous system disorders. For more
information, visit us at www.Acadia.com and follow us on LinkedIn
and Twitter.
Address
12830 El Camino Real, Suite 400
San Diego, CA 92130
Main Phone Number
(858) 558-2871
Fax
(858) 558-2872